Search results
Added:
1 year ago
ISET 2025 - How have drug delivery devices changed over the years, and what are the novel technologies and therapeutic agents?Dr Marianne Brodmann (Medical University of Graz, AT) joins us onsite at ISET 2025 to discuss the current landscape of drug delivery devices, from paclitaxel drug-coated balloons to drug-eluting stents. Dr Brodmann discusses evolving technologies, including bioresorbable…
View more
Added:
2 days ago
EuroPCR 2026 – Prof Bruno Scheller (Saarland University Hospital, Homburg, DE) joins us to explore the evolving role of drug-coated balloons in coronary intervention, discussing the latest trial evidence and how it is shaping clinical practice.Interview Questions:How has the role of DCBs in coronary intervention evolved over recent years?What does the latest trial evidence add to our…
View more
Added:
6 days ago
Drug-coated Balloon Angioplasty in Sri Lanka
Added:
6 months ago
Original Research
Added:
3 weeks ago
EuroPCR 2026 – Dr Brian Bergmark (Brigham and Women's Hospital, Boston, MA, US) joins us to discuss findings from the VESALIUS-CV trial, examining the effect of evolocumab in patients who have undergone coronary stenting but have no prior myocardial infarction or stroke.VESALIUS-CV is a double-blind, randomised, placebo-controlled, multicentre phase 3 trial enrolling 12,301 high-cardiovascular…
View more
Added:
11 months ago
Source:
Radcliffe Cardiology
AUTHOR: Greg GuilloryThe selection of drug-eluting stents (DES) for percutaneous coronary intervention (PCI) involves balancing efficacy against safety. The SORT OUT XI randomised trial aimed to compare a newer-generation biolimus-eluting stent with a contemporary dual-therapy sirolimus-eluting stent in a real-world patient population, providing crucial head-to-head evidence.¹SORT OUT XI was a…
View more
Added:
1 month ago
In this expert discussion, Dr Karim Al‑Azizi (Baylor Scott & White The Heart Hospital, US) is joined by co–principal investigator Dr William Fearon (Stanford University School of Medicine / Stanford Health Care, US) and coronary physiology specialist Dr Evan Shlofmitz (St Francis Hospital & Heart Center, Roslyn, US) to explore where angiography‑derived FFR fits alongside established wire‑based…
View more
Added:
1 year ago
LINC 2025 - 12-month amputation and readmission rates from the TRUE-PTX study suggests endovascular revascularisation for peripheral artery disease (PAD) with drug-eluting devices lead to better outcomes than with bare device therapies.Dr Marianne Brodmann (Medical University of Graz, AT) joins us to discuss the TRUE-PTX study evaluating a database of patients in the US with PAD who have recieved…
View more
Stent Underexpansion and Aorto-ostial Lesions Management
Added:
1 year ago
Review Article
Stenting Strategies in Left Main Bifurcation
Added:
4 months ago
Systematic Review